Avalo Therapeutics, Inc. earnings per share and revenue

AVTX earnings per share for the last quarter are -10.10 USD whereas the estimation was -4.80 USD which accounts for -110.42% surprise. Company revenue for the same period amounts to 574.00 k USD despite the estimated figure of 300.00 k USD. Estimated earnings per share for the next quarter are -1.18 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of AVTX earnings per share and revenue dynamics.